N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors
Journal of Medicinal Chemistry · 22.08.2024 · 67 (16) · 13737-13764
DOI: 10.1021/acs.jmedchem.4c00527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.08.2024. Verfasst von Destiny Durante und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States. Hauptthemen laut MEDLINE: Pyrroles, Antiviral Agents, Ebolavirus, Virus Internalization. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, U.S. Department of Health and Human Services.
Abstract (Originalsprache)
Since the largest and most fatal Ebola virus epidemic during 2014-2016, there have been several consecutive filoviral outbreaks in recent years, including those in 2021, 2022, and 2023. Ongoing outbreak prevalence and limited FDA-approved filoviral therapeutics emphasize the need for novel small molecule treatments. Here, we showcase the structure-activity relationship development of N-substituted pyrrole-based heterocycles and their potent, submicromolar entry inhibition against diverse filoviruses in a target-based pseudovirus assay. Inhibitor antiviral activity was validated using replication-competent Ebola, Sudan, and Marburg viruses. Mutational analysis was used to map the targeted region within the Ebola virus glycoprotein. Antiviral counter-screen and phospholipidosis assays were performed to demonstrate the reduced off-target activity of these filoviral entry inhibitors. Favorable antiviral potency, selectivity, and drug-like properties of the N-substituted pyrrole-based heterocycles support their potential as broad-spectrum antifiloviral treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Illinois Chicago, Chicago, Illinois 60612, United States.
- Department of Microbiology and Immunology, University of Illinois Chicago, Chicago, Illinois 60612, United States.
- Department of Virology, Immunology, and Microbiology, National Emerging Infectious Diseases Laboratories, Boston University Medical Campus, Boston, Massachusetts 02118, United States.
- UICentre: Drug Discovery, University of Illinois Chicago, Chicago, Illinois 60612, United States.
- Chicago BioSolutions Inc., Chicago, Illinois 60612, United States.
- University of Illinois Cancer Center, University of Illinois Chicago, Chicago, Illinois 60612, United States.
ORCID-Profile: Destiny Durante, Kimberly M Morsheimer, J J Patten, Robert A Davey, Irina N Gaisina, Terry W Moore
Förderung
- NIAID NIH HHS
- U.S. Department of Health and Human Services
Zitieren
APA
Durante, D., Bott, R., Cooper, L., Owen, C., Morsheimer, K. M., Patten, J. J., Zielinski, C., Peet, N. P., Davey, R. A., Gaisina, I. N., Rong, L., & Moore, T. W. (2024). N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors. Journal of Medicinal Chemistry, 67(16), 13737-13764. https://doi.org/10.1021/acs.jmedchem.4c00527
Vancouver
Durante D, Bott R, Cooper L, Owen C, Morsheimer KM, Patten JJ, et al. N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors. Journal of Medicinal Chemistry. 2024;67(16):13737-13764. doi:10.1021/acs.jmedchem.4c00527
BibTeX
@article{Durante2024,
author = {Durante, Destiny and Bott, Ryan and Cooper, Laura and Owen, Callum and Morsheimer, Kimberly M and Patten, J J and Zielinski, Christian and Peet, Norton P and Davey, Robert A and Gaisina, Irina N and Rong, Lijun and Moore, Terry W},
title = {N-Substituted Pyrrole-Based Heterocycles as Broad-Spectrum Filoviral Entry Inhibitors},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {16},
pages = {13737--13764},
doi = {10.1021/acs.jmedchem.4c00527}
}
EUVIMED